|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/00 |
| (11) | Number of the document | 2521776 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11731733.9 |
| Date of filing the European patent application | 2011-01-05 | |
| (97) | Date of publication of the European application | 2012-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2011/000007 |
| Date | 2011-01-05 |
| (87) | Number | WO 2011/083464 |
| Date | 2011-07-14 |
| (30) | Number | Date | Country code |
| 282247 P | 2010-01-07 | US | |
| 282228 P | 2010-01-05 | US |
| (72) |
COHEN, Yael, IL
SHER, Naamit, IL
FEIGE, Erez, IL
BANGIO, Livnat, IL
BREITBART, Eyal, IL
|
| (73) |
Vascular Biogenics Ltd.,
6 Jonathan Netanyahu Street, 60376 Or Yehuda,
IL
|
| (54) | METHODS FOR USE OF A SPECIFIC ANTI-ANGIOGENIC ADENOVIRAL AGENT |
| METHODS FOR USE OF A SPECIFIC ANTI-ANGIOGENIC ADENOVIRAL AGENT |